Related Experiment Videos
Biochemical findings in symptomatic dystonias
J G de Yebenes1, A Vazquez, A Martinez
1Hospital Clinico de S. Carlos, Ciudad Universitaria, Madrid, Spain.
Advances in Neurology
|January 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A novel entorhinal projection to the rat dentate gyrus: direct innervation of proximal dendrites and cell bodies of granule cells and GABAergic neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience·1996
Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.
Gastroenterology·1996
Mutational analysis and secondary structure model of the RNP1-like sequence motif of transcription termination factor Rho.
Journal of molecular biology·1996
Residues in the RNP1-like sequence motif of Rho protein are involved in RNA-binding affinity and discrimination.
Journal of molecular biology·1996
Effects of continuous low-dose-rate brachytherapy on the rectum of the rat.
Radiation research·1996
Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
The American journal of tropical medicine and hygiene·1996
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Where metabolism and virulence meet-sulfoxide reductases as determinants of bacterial survival.
Biochemical Society transactions·2026
Mitochondrial dynamics in Huntington's disease.
Journal of Huntington's disease·2026
Fructose directly remodels the translocase of the outer membrane to impair oxidative phosphorylation in podocytes.
Signal transduction and targeted therapy·2026